Recordati S.p.A. - Board of Directors

Board of Directors

To view the biographies click on the names of the directors below.

Giovanni Recordati Chairman and Chief Executive Officer

Giovanni Recordati holds a degree in chemical engineering from the Politecnico di Milano and a master's degree in Management Sciences from Imperial College London.
He joined Recordati in 1974 as a researcher. In 1980, he was appointed as Central Production Manager and, in 1984, as Deputy General Manager for Operations and Research. In 1990, he was appointed Chief Executive Officer with responsibility for managing the operational activities of the Group's Italian and foreign companies. He has been a member of the Board of Directors since 1977. Presently he is Chairman, Chief Executive Officer and general manager of Recordati S.p.A. as well as holding positions in other group positions.

Alberto Recordati Vice Chairman

Alberto Recordati graduated from University of London King's College in 1977 with a degree in biochemistry and in 1984 successfully completed a research PhD within the Biochemistry Department of Charing Cross Hospital Medical School part of that same university.
He joined Recordati in 1984 as a researcher in the biochemistry laboratories. In 1987 he was appointed Head of the Planning and Product Development Office. From 1990 to 1992, he worked for the US subsidiary Pharmetrix Corp as research project coordinator. In 1992 he was appointed industrial Manager for Biochemicals with responsibility for biochemical/microbiological research and for the Cascina dè Pecchi biochemical/fermentation production site. In 1995, he became Head of the Chemical Research and Technologies Division. In 1999, he was appointed director in charge of the fine chemicals sector and in 2004 Deputy Chairman of Recordati S.p.A. He was held responsibility for co-ordinating the "Drug Discovery" and "Drug Development" activietis of the Company since 2008 and also for licensing-in activities since 2011.

Silvano Corbella University Professor - Economist and Business Consultant

Silvano Corbella was born in Novara, April 18th 1965. After he received the degree in Business Administration at Bocconi University in Milan, he began the academic career, teaching at Bocconi University, SDA Bocconi, Libero Istituto Universitario Carlo Cattaneo in Castellanza and Cattolica University in Cremona. In 1994 he joined the University of Verona as Assistant Professor. At the same time, and until 2008, he taught at SDA Bocconi, where for nearly a decade he was also tenured of the Financial Accounting course at the Master in Business Administration. At the beginning of 2011, after various career steps, he became Full Professor at the University of Verona, where he has been teaching Accounting and carrying out his research activity for 15 years.
He is Chartered Accountant and Auditor and holds various assignments: he is Chairman and/or Supervisory Body member of both listed and unlisted companies and of an American Merchant Bank branch. Moreover, he is member of several Boards of Statutory Auditors. In relation to his professional activity, he provided capital evaluations for different purposes, also with regard to listed companies, and financial – economic opinions; he has been an accounting expert of Arbitral Board and of civil and penal proceedings.
He is author of several articles and four monographs on topics related to internal audit system, financial statement and stock options. With regard to these topics, he is a regular speaker at conferences and workshops.

Prof. Silvano Corbella is member of the Board of Statutory Auditors of the following companies:
1. Leonardo & Co S.p.A.
2. Euraleo S.r.l.
3. Growermetal S.r.l.
4. Procos S.p.A.
5. IUAV Studi & Progetti – ISP S.r.l.
6. Ivri Direzione S.p.A.
7. I.V.R.I. Istituti di Vigilanza Riuniti S.p.A. (Milan)

Prof. Silvano Corbella is, also, member of the Board of Directors of EVS Embedded Vision Systems S.r.l.

Mario Garraffo Former Senior Advisor GE Europe

Mario Garraffo graduated in 1960 with a degree in Economics and Commerce from the Università Bocconi di Milano.
Between 1960 and 1970, he was Controller and Development Director of La Centrale Finanziaria Generale, a holding company principally involved in the area of public services (communications and energy). From 1970 to 1980, he was Investment Director at the IFI group; from 1980 to 1985 he was Chief Executive Officer of IFIL - Finanziaria di Partecipazioni and from 1985 to 1993 Chairman of IFINT (now EXOR).
In 1993, he was appointed Chief Executive Officer of Lazard Italia until the acquisition of Vitale, Borghesi & Co. in 1998. Again in 1998, he was appointed Chief Executive Officer of UNIM, a post which he held until 2000 and as Chairman of General Electric Italia from 2000 to 2004. He was a Senior Advisor for General Electric Europe from 2004 until 2007.
He is an independent director, member of the Internal Audit Committee and of the Remuneration Committee of the Recordati S.p.A.. He has been a Trustee of the Johns Hopkins University of Baltimore and a Trustee of the Johns Hopkins School for Advanced International Studies (SAIS) in Bologna.
From 1995 to 2006 he was President of the Università Bocconi Alumni Association and member of the Board of Directors of the Donna Javotte Bocconi Foundation (founding entity of the Università Bocconi).

Dr. Garraffo holds the following additional positions:

- Chairman IVG SGR SPA
- Chairman METIS SpA
- Director GE INTERBANCA SPA

Germano Giuliani President Giuliani S.p.A.

Mario Germano Giuliani was born in London on February 26th 1972 and he holds a degree in Economy and Commerce from the Catholic University of Sacred Heart in Milan, Italy.
He starts his career in the pharmaceutical industry in 1996 in Giuliani SpA where he works in marketing, sales, finance and control.
In 1998 and 1999, Mr. Giuliani was an investment professional with Vector Fund Management, a private equity firm focused on healthcare and life sciences with approximately $250 million under management.
After his experience in the US, Mr. Giuliani re-joins Giuliani SpA as chief financial officer until 2001. In 2001 he becomes chief executive officer and in 2003 president.

Umberto Mortari Former Chairman and CEO Merck Sharp & Dohme (Italy) S.p.A.

Umberto Mortari was born in Milan on October 27th, 1946. He got a degree in Law at the “La Sapienza” University of Rome. He attended different Business and Management Programs at INSEAD and at the Business Schools of Harvard University and Michigan University.
In June 2001 he was awarded by the University of Chieti “G.D’Annunzio” an HC degree in Medicine and in September 2005, by the University of Pavia, an HC degree in Pharmacy.
He joined Merck Sharp & Dohme (Italia) S.p.A. in 1972, where he held various positions in the areas of Marketing, Sales and Business Planning Research.
In 1981 he was appointed Marketing Director, in 1986 Director of Pharmaceutical Division, in 1987 member of the Board of Directors and Managing Director in 1991.
Since January 1992 to December 2007 he became President, Manging Director and Vice President of Merck Europe. He has held the following positions in other companies of Merck Italia Group: President and Managing Director of Neopharmed in Milan; President and Managing Director of the Istituto Gentili in Pisa; member of the Board of Directors of the Istituto di Ricerche Biomolecolari-Pietro Angeletti in Pomezia and President of the MSD Foundation.
Member of FARMINDUSTRIA Board, where he was Vice President for eight years.
He was also President of the Center of Clinical Phisiology and Hypertension of the University of Milan; Vice President of the Forum for Biomedical Research of CENSIS and member of the Board of the Italian Society of Pharmaceuticals Sciences.
Currently he is President of the “Accademia degli Incolti”, President of the Executive Committee of Gaffi Editore in Rome and member of Visufarma S.p.A. Board of Directors.

Carlo Pedersoli Partner Pedersoli e Associati law firm

Carlo Pedersoli was admitted to the Milan bar in 1980.
A partner in the Pedersoli e Associati law firm, he is a civil lawyer who deals predominantly in company and commercial law for national and international clients operating both in the financial/banking sector and in the industrial sector. He has spoken at conferences on company and commercial law, analysing the topic of financial statements, validity of shareholders' resolutions and responsibility of auditors.
As well as forming part of the Board of Directors and of the Internal Audit Committee of Recordati S.p.A., he is also a member of the Board of Directors of Welfare Italia Servizi S.r.l.
He has also been a Director of the companies Riello S.p.A., Sigla Engineering S.p.A., Nextam Partners SGR S.p.A. and Chairman of the company Sistemi Tecnologici Holding S.p.A., the holding company of Sistemi Tecnologici S.p.A. which is in turn the holding company of Sirti S.p.A.

Andrea Recordati General Manager Pharmaceuticals International

Andrea Recordati gained a Bachelor of Arts in medieval and modern history from the University of London Royal Holloway and Bedford New College. Between September 1995 and March 1998, he took part in the United Kingdom SmithKline Beecham Management Access Program, starting off as Assistant Product Manager in Consumer Healthcare and then, for one year, occupying the role of medical representative in Essex before becoming Project Manager responsible for the development and implementation of an innovative SmithKline Beecham marketing initiative.
He joined Recordati in 1998 as Project Leader for a project aimed at improving Sales Force productivity and better use of marketing investments. In April 1998, he joined the Board of Directors of the Company.
In 1999, he was given responsibility for Pharmaceutical Business Development.
In March 2002, the Lercanidipine Business Unit was set up and he was appointed head of that unit. Since November 2002, he has been responsible for setting up the subsidiary Recordati Ireland and its industrial plant and, subsequently, for setting up the UK subsidiary. In September 2006, he was appointed Managing Director with sole right of representation of the German subsidiary Merckle Recordati GmbH. In August 2007, the Northern and Central Europe Branches Division was set up and he was appointed head of that division. That division was enlarged in 2010 to include western European companies. In February 2011 he was appointed General Manager of the International Pharmaceuticals Division.

Marco Vitale Economist and Business Consultant

Marco Vitale business economist. He has teached for several years business economy at Pavia University; Bocconi University, Milan; Libero Istituto Universitario Carlo Cattaneo (for which he was vice-president, President of the Scientific Committee, and responsible for management area and which he contributed to create). He has been chairman of Istud (Foundation for the business culture and management), which he also contributed to relaunch, and has been co-ordinator for management area of ISTAO, post-degree management school founded by the economist Prof. Giorgio Fuà.
Former partner of Arthur Andersen & Co., he is founding partner and president of Vitale–Novello & Co. S.r.l., top management consulting firm. In this context he is consultant and member of the board of directors for many important companies.
He is President from March 2010 of Fondo Italiano di Investimenti SGR SpA, constituted by the Treasure Ministry, Confindustria, ABI, Banca Intesa, Unicredit, Monte Paschi, Crediop and some popular banks, with a capital of 1.2 billion Euro, with the aim of sustaining development projects and internationalization of little medium companies.
He has been president from 1984 till 2003 of A.I.F.I. (Italian Venture Capital and Private Equity Association) and promoter and first president of Arca Group, the mutual fund company of popular banks. He has been Vice-president, member of the board and of the Executive Committee of Banca Popolare of Milan from 2001 till 2009 and was Chairman of Bipiemme Gestioni S.G.R., the Asset Management Company of the BPM Group.
President of the Rino Snaidero Scientific Foundation; President of the Scientific Committee of AIdAF (the Italian Family Business Association); member of the Board of Olivetti Foundation; member of the Board of FAI Foundation.
He has been appointed to several important public tasks.
He contributes to important leading newspapers and business magazines.
He published several books including:
Società, bilanci e borse valori in un mercato mobiliare evoluto (Etas-Kompass); La riforma delle società per azioni (Giuffré); La lunga marcia verso il capitalismo democratico (Ed. Il Sole-24 Ore); Liberare l’economia: le privatizzazioni come terapia alla crisi italiana (Ed. Marsilio); Le Encicliche sociali, il rapporto fra la Chiesa e l’economia (Ed. Il Sole-24 ore); Sviluppo e Spirito d’Impresa (Ed. Il Veltro); America. Punto e a capo (Scheiwiller); Il Mito Alfa (Egea editore, Bocconi); Lezioni di Impresa, da tempi e luoghi diversi – I proverbi di Calatafimi (Piccola Biblioteca Inaz, 2008); Gli angeli nella città (ESD Edizioni); Passaggio al Futuro, Oltre la Crisi attraverso la Crisi (Ed. Egea, Bocconi); Corruzione (ESD Bologna 2010); Responsabilità nell’impresa (Piccola Biblioteca d’Impresa Inaz, 2010).
He was editor in Italy and USA of the bilingual version of the essay of Carlo Cattaneo: “Intelligence as a principle of public economy”.
Good mountain - climber, he has covered great part of Italy by bicycle, a good way to observe the Italian economy as it really is and not as people say to be.

Prof. Vitale holds the following additional positions:
- Director ETICA SGR SpA.
- Director SAME DEUTZ FAHR SpA.
- Chairman SAME DEUTZ FAHR ITALIA SpA.
- Director ERMENEGILDO ZEGNA HOLDITALIA SpA.
- Chairman of the Board of Directors of VINCENZO ZUCCHI SpA.
- Director Snaidero SpA.
- Director LUVE.
- Director SMEG.
- Director Banca Passadore.
- Chairman of the Fondo Italiano d’Investimento

Walter Wenninger Former Member of the Board of Management Bayer AG

Walter Wenninger has worked for more than 30 years in the international healthcare industry in Germany, Europe and USA.
He has been a member of the Board of Management at Bayer AG, Germany, responsible for life science and health care and Chairman of the Board of Bayer Corp. Pittsburg, USA.
He has been a member of the Board of Trustees of the German Cancer Research Centre of Heidelberg and of the German Cardiac Research Foundation of Frankfurt.
He currently occupies various positions on the boards of directors of European biopharmaceutical companies and he is a member of the executive committee of the Robert-Koch-Foundation in Germany.

Wenninger holds positions in the following companies:

- Chairman of the Board of Directors of Paion AG, Aachen, Germany.
- Chairman of the Board of Directors of Noxxon Pharma AG, Berlin, Germany.
- Deputy Chairman of the Board of Directors of Santaris Pharma, Horsholm, Denmark.
- Deputy Chairman of the Board of Directors of Evotec AG, Hamburg, Germany.
- Member of the Novo A/S Advisory Group, Hellerup, Denmark, since Sept. 2010.